These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10809747)

  • 1. Probing the active site of the hepatitis C virus serine protease by fluorescence resonance energy transfer.
    Fattori D; Urbani A; Brunetti M; Ingenito R; Pessi A; Prendergast K; Narjes F; Matassa VG; De Francesco R; Steinkühler C
    J Biol Chem; 2000 May; 275(20):15106-13. PubMed ID: 10809747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational changes in human hepatitis C virus NS3 protease upon binding of product-based inhibitors.
    Bianchi E; Orrù S; Dal Piaz F; Ingenito R; Casbarra A; Biasiol G; Koch U; Pucci P; Pessi A
    Biochemistry; 1999 Oct; 38(42):13844-52. PubMed ID: 10529230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells.
    Hamill P; Jean F
    Biochemistry; 2005 May; 44(17):6586-96. PubMed ID: 15850392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Product inhibition of the hepatitis C virus NS3 protease.
    Steinkühler C; Biasiol G; Brunetti M; Urbani A; Koch U; Cortese R; Pessi A; De Francesco R
    Biochemistry; 1998 Jun; 37(25):8899-905. PubMed ID: 9636031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of charged residues in the catalytic mechanism of hepatitis C virus NS3 protease: electrostatic precollision guidance and transition-state stabilization.
    Koch U; Biasiol G; Brunetti M; Fattori D; Pallaoro M; Steinkühler C
    Biochemistry; 2001 Jan; 40(3):631-40. PubMed ID: 11170379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping.
    Landro JA; Raybuck SA; Luong YP; O'Malley ET; Harbeson SL; Morgenstern KA; Rao G; Livingston DJ
    Biochemistry; 1997 Aug; 36(31):9340-8. PubMed ID: 9235976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steady-state cleavage kinetics for dengue virus type 2 ns2b-ns3(pro) serine protease with synthetic peptides.
    Khumthong R; Niyomrattanakit P; Chanprapaph S; Angsuthanasombat C; Panyim S; Katzenmeier G
    Protein Pept Lett; 2003 Feb; 10(1):19-26. PubMed ID: 12625822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prime site binding inhibitors of a serine protease: NS3/4A of hepatitis C virus.
    Ingallinella P; Fattori D; Altamura S; Steinkühler C; Koch U; Cicero D; Bazzo R; Cortese R; Bianchi E; Pessi A
    Biochemistry; 2002 Apr; 41(17):5483-92. PubMed ID: 11969409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3.
    Butkiewicz N; Yao N; Zhong W; Wright-Minogue J; Ingravallo P; Zhang R; Durkin J; Standring DN; Baroudy BM; Sangar DV; Lemon SM; Lau JY; Hong Z
    J Virol; 2000 May; 74(9):4291-301. PubMed ID: 10756044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase.
    De Francesco R; Pessi A; Steinkühler C
    Antivir Ther; 1998; 3(Suppl 3):99-109. PubMed ID: 10726060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide-based inhibitors of the hepatitis C virus serine protease.
    Llinàs-Brunet M; Bailey M; Fazal G; Goulet S; Halmos T; Laplante S; Maurice R; Poirier M; Poupart MA; Thibeault D; Wernic D; Lamarre D
    Bioorg Med Chem Lett; 1998 Jul; 8(13):1713-8. PubMed ID: 9873421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR line-broadening and transferred NOESY as a medicinal chemistry tool for studying inhibitors of the hepatitis C virus NS3 protease domain.
    LaPlante SR; Aubry N; Bonneau PR; Kukolj G; Lamarre D; Lefebvre S; Li H; Llinàs-Brunet M; Plouffe C; Cameron DR
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2271-4. PubMed ID: 11055336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redesigning the substrate specificity of the hepatitis C virus NS3 protease.
    Failla CM; Pizzi E; De Francesco R; Tramontano A
    Fold Des; 1996; 1(1):35-42. PubMed ID: 9079362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus NS3/4A protease.
    Kwong AD; Kim JL; Rao G; Lipovsek D; Raybuck SA
    Antiviral Res; 1999 Feb; 41(1):67-84. PubMed ID: 10321580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple determinants influence complex formation of the hepatitis C virus NS3 protease domain with its NS4A cofactor peptide.
    Urbani A; Biasiol G; Brunetti M; Volpari C; Di Marco S; Sollazzo M; Orrú S; Piaz FD; Casbarra A; Pucci P; Nardi C; Gallinari P; De Francesco R; Steinkühler C
    Biochemistry; 1999 Apr; 38(16):5206-15. PubMed ID: 10213628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The conformation of hepatitis C virus NS3 proteinase with and without NS4A: a structural basis for the activation of the enzyme by its cofactor.
    Love RA; Parge HE; Wickersham JA; Hostomsky Z; Habuka N; Moomaw EW; Adachi T; Margosiak S; Dagostino E; Hostomska Z
    Clin Diagn Virol; 1998 Jul; 10(2-3):151-6. PubMed ID: 9741640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A.
    Gallinari P; Paolini C; Brennan D; Nardi C; Steinkühler C; De Francesco R
    Biochemistry; 1999 Apr; 38(17):5620-32. PubMed ID: 10220351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase.
    Yao N; Reichert P; Taremi SS; Prosise WW; Weber PC
    Structure; 1999 Nov; 7(11):1353-63. PubMed ID: 10574797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of the hepatitis C virus NS3 serine protease: effects of substitutions at the 3/4A, 4A/4B, 4B/5A, and 5A/5B cleavage sites on polyprotein processing.
    Kolykhalov AA; Agapov EV; Rice CM
    J Virol; 1994 Nov; 68(11):7525-33. PubMed ID: 7933136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The design and synthesis of potent inhibitors of hepatitis C virus NS3-4A proteinase.
    Attwood MR; Bennett JM; Campbell AD; Canning GG; Carr MG; Conway E; Dunsdon RM; Greening JR; Jones PS; Kay PB; Handa BK; Hurst DN; Jennings NS; Jordan S; Keech E; O'Brien MA; Overton HA; King-Underwood J; Raynham TM; Stenson KP; Wilkinson CS; Wilkinson TC; Wilson FX
    Antivir Chem Chemother; 1999 Sep; 10(5):259-73. PubMed ID: 10574181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.